Fusion Gene Studies
in Kim Lab

FusionBase FusionGDB FusionGDB2 FusionPDB FusionNeoAntigen FusionAI FusionNW FGviewer Publication Contact
FusionGDB Logo

Home

Download

Statistics

Examples

Help

Contact
Center for Computational Systems Medicine
leaf

Fusion Gene Summary

leaf

Fusion Gene ORF analysis

leaf

Fusion Genomic Features

leaf

Fusion Protein Features

leaf

Fusion Gene Sequence

leaf

Fusion Gene PPI analysis

leaf

Related Drugs

leaf

Related Diseases

Fusion gene:SPP1-CTNNA2 (FusionGDB2 ID:HG6696TG1496)

Fusion Gene Summary for SPP1-CTNNA2

check button Fusion gene summary
Fusion gene informationFusion gene name: SPP1-CTNNA2
Fusion gene ID: hg6696tg1496
HgeneTgene
Gene symbol

SPP1

CTNNA2

Gene ID

6696

1496

Gene namesecreted phosphoprotein 1catenin alpha 2
SynonymsBNSP|BSPI|ETA-1|OPNCAP-R|CAPR|CDCBM9|CT114|CTNR
Cytomap('SPP1')('CTNNA2')

4q22.1

2p12

Type of geneprotein-codingprotein-coding
DescriptionosteopontinSPP1/CALPHA1 fusionearly T-lymphocyte activation 1nephropontinosteopontin/immunoglobulin alpha 1 heavy chain constant region fusion proteinsecreted phosphoprotein 1 (osteopontin, bone sialoprotein I, early T-lymphocyte activation 1)secretcatenin alpha-2alpha-N-cateninalpha-catenin-related proteincadherin-associated protein, relatedcancer/testis antigen 114catenin (cadherin-associated protein), alpha 2
Modification date2020032920200313
UniProtAcc..
Ensembl transtripts involved in fusion geneENST00000237623, ENST00000509659, 
ENST00000360804, ENST00000395080, 
Fusion gene scores* DoF score9 X 6 X 5=27026 X 24 X 10=6240
# samples 928
** MAII scorelog2(9/270*10)=-1.58496250072116
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0		log2(28/6240*10)=-4.47804729680464
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
Context

PubMed: SPP1 [Title/Abstract] AND CTNNA2 [Title/Abstract] AND fusion [Title/Abstract]

Most frequent breakpointSPP1(88904480)-CTNNA2(80622117), # samples:1
Anticipated loss of major functional domain due to fusion event.
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types
** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10)

check button Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez
PartnerGeneGO IDGO termPubMed ID
HgeneSPP1

GO:0006710

androgen catabolic process

26482249

HgeneSPP1

GO:0007155

cell adhesion

25839998

HgeneSPP1

GO:0033280

response to vitamin D

16720713

HgeneSPP1

GO:0045893

positive regulation of transcription, DNA-templated

26482249

HgeneSPP1

GO:0071394

cellular response to testosterone stimulus

26482249

HgeneSPP1

GO:2000866

positive regulation of estradiol secretion

26482249



check button Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0)
* All genome coordinats were lifted-over on hg19.
* Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser.
SourceDiseaseSampleHgeneHchrHbpHstrandTgeneTchrTbpTstrand
ChiTaRS5.0N/AAW021049SPP1chr4

88904480

+CTNNA2chr2

80622117

-


Top

Fusion Gene ORF analysis for SPP1-CTNNA2

check button Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure.
* Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser.
ORFHenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrand
3UTR-intronENST00000237623ENST00000343114SPP1chr4

88904480

+CTNNA2chr2

80622117

-
3UTR-intronENST00000237623ENST00000361291SPP1chr4

88904480

+CTNNA2chr2

80622117

-
3UTR-intronENST00000237623ENST00000402739SPP1chr4

88904480

+CTNNA2chr2

80622117

-
3UTR-intronENST00000237623ENST00000409266SPP1chr4

88904480

+CTNNA2chr2

80622117

-
3UTR-intronENST00000237623ENST00000466387SPP1chr4

88904480

+CTNNA2chr2

80622117

-
3UTR-intronENST00000237623ENST00000496251SPP1chr4

88904480

+CTNNA2chr2

80622117

-
3UTR-intronENST00000237623ENST00000496558SPP1chr4

88904480

+CTNNA2chr2

80622117

-
3UTR-intronENST00000237623ENST00000540488SPP1chr4

88904480

+CTNNA2chr2

80622117

-
3UTR-intronENST00000237623ENST00000541047SPP1chr4

88904480

+CTNNA2chr2

80622117

-
5CDS-intronENST00000509659ENST00000343114SPP1chr4

88904480

+CTNNA2chr2

80622117

-
5CDS-intronENST00000509659ENST00000361291SPP1chr4

88904480

+CTNNA2chr2

80622117

-
5CDS-intronENST00000509659ENST00000402739SPP1chr4

88904480

+CTNNA2chr2

80622117

-
5CDS-intronENST00000509659ENST00000409266SPP1chr4

88904480

+CTNNA2chr2

80622117

-
5CDS-intronENST00000509659ENST00000466387SPP1chr4

88904480

+CTNNA2chr2

80622117

-
5CDS-intronENST00000509659ENST00000496251SPP1chr4

88904480

+CTNNA2chr2

80622117

-
5CDS-intronENST00000509659ENST00000496558SPP1chr4

88904480

+CTNNA2chr2

80622117

-
5CDS-intronENST00000509659ENST00000540488SPP1chr4

88904480

+CTNNA2chr2

80622117

-
5CDS-intronENST00000509659ENST00000541047SPP1chr4

88904480

+CTNNA2chr2

80622117

-
intron-intronENST00000360804ENST00000343114SPP1chr4

88904480

+CTNNA2chr2

80622117

-
intron-intronENST00000360804ENST00000361291SPP1chr4

88904480

+CTNNA2chr2

80622117

-
intron-intronENST00000360804ENST00000402739SPP1chr4

88904480

+CTNNA2chr2

80622117

-
intron-intronENST00000360804ENST00000409266SPP1chr4

88904480

+CTNNA2chr2

80622117

-
intron-intronENST00000360804ENST00000466387SPP1chr4

88904480

+CTNNA2chr2

80622117

-
intron-intronENST00000360804ENST00000496251SPP1chr4

88904480

+CTNNA2chr2

80622117

-
intron-intronENST00000360804ENST00000496558SPP1chr4

88904480

+CTNNA2chr2

80622117

-
intron-intronENST00000360804ENST00000540488SPP1chr4

88904480

+CTNNA2chr2

80622117

-
intron-intronENST00000360804ENST00000541047SPP1chr4

88904480

+CTNNA2chr2

80622117

-
intron-intronENST00000395080ENST00000343114SPP1chr4

88904480

+CTNNA2chr2

80622117

-
intron-intronENST00000395080ENST00000361291SPP1chr4

88904480

+CTNNA2chr2

80622117

-
intron-intronENST00000395080ENST00000402739SPP1chr4

88904480

+CTNNA2chr2

80622117

-
intron-intronENST00000395080ENST00000409266SPP1chr4

88904480

+CTNNA2chr2

80622117

-
intron-intronENST00000395080ENST00000466387SPP1chr4

88904480

+CTNNA2chr2

80622117

-
intron-intronENST00000395080ENST00000496251SPP1chr4

88904480

+CTNNA2chr2

80622117

-
intron-intronENST00000395080ENST00000496558SPP1chr4

88904480

+CTNNA2chr2

80622117

-
intron-intronENST00000395080ENST00000540488SPP1chr4

88904480

+CTNNA2chr2

80622117

-
intron-intronENST00000395080ENST00000541047SPP1chr4

88904480

+CTNNA2chr2

80622117

-

check buttonORFfinder result based on the fusion transcript sequence of in-frame fusion genes.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandSeq length
(transcript)		BP loci
(transcript)		Predicted start
(transcript)		Predicted stop
(transcript)		Seq length
(amino acids)

check buttonDeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandNo-coding scoreCoding score

Top

Fusion Genomic Features for SPP1-CTNNA2


check buttonFusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints.
HgeneHchrHbpHstrandTgeneTchrTbpTstrand1-pp (fusion gene breakpoint)


Top

Fusion Protein Features for SPP1-CTNNA2


check button Four levels of functional features of fusion genes
Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/:88904480/:80622117)
- FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels.
- How to search
1. Put your fusion gene symbol.
2. Press the tab key until there will be shown the breakpoint information filled.
4. Go down and press 'Search' tab twice.
4. Go down to have the hyperlink of the search result.
5. Click the hyperlink.
6. See the FGviewer result for your fusion gene.
FGviewer

check buttonMain function of each fusion partner protein. (from UniProt)
HgeneTgene
..
FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}.FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}.

check buttonRetention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at

download page


* Minus value of BPloci means that the break pointn is located before the CDS.
- In-frame and retained protein feature among the 13 regional features.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note

- In-frame and not-retained protein feature among the 13 regional features.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note


Top

Fusion Gene Sequence for SPP1-CTNNA2


check button For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones.

Top

Fusion Gene PPI Analysis for SPP1-CTNNA2


check button Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in

ChiPPI page.


check button Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160)
HgeneHgene's interactorsTgeneTgene's interactors


check button - Retained PPIs in in-frame fusion.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenStill interaction with


check button - Lost PPIs in in-frame fusion.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenInteraction lost with


check button - Retained PPIs, but lost function due to frame-shift fusion.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenInteraction lost with


Top

Related Drugs for SPP1-CTNNA2


check button Drugs targeting genes involved in this fusion gene.
(DrugBank Version 5.1.8 2021-05-08)
PartnerGeneUniProtAccDrugBank IDDrug nameDrug activityDrug typeDrug status

Top

Related Diseases for SPP1-CTNNA2


check button Diseases associated with fusion partners.
(DisGeNet 4.0)
PartnerGeneDisease IDDisease name# pubmedsSource
HgeneSPP1C0024141Lupus Erythematosus, Systemic5ORPHANET
HgeneSPP1C0001418Adenocarcinoma2CTD_human
HgeneSPP1C0003949Asbestosis2CTD_human
HgeneSPP1C0006142Malignant neoplasm of breast2CTD_human
HgeneSPP1C0006663Calcinosis2CTD_human
HgeneSPP1C0022650Kidney Calculi2CTD_human
HgeneSPP1C0022660Kidney Failure, Acute2CTD_human
HgeneSPP1C0024121Lung Neoplasms2CTD_human
HgeneSPP1C0025500Mesothelioma2CTD_human
HgeneSPP1C0205641Adenocarcinoma, Basal Cell2CTD_human
HgeneSPP1C0205642Adenocarcinoma, Oxyphilic2CTD_human
HgeneSPP1C0205643Carcinoma, Cribriform2CTD_human
HgeneSPP1C0205644Carcinoma, Granular Cell2CTD_human
HgeneSPP1C0205645Adenocarcinoma, Tubular2CTD_human
HgeneSPP1C0242379Malignant neoplasm of lung2CTD_human
HgeneSPP1C0263628Tumoral calcinosis2CTD_human
HgeneSPP1C0521174Microcalcification2CTD_human
HgeneSPP1C0678222Breast Carcinoma2CTD_human
HgeneSPP1C1257931Mammary Neoplasms, Human2CTD_human
HgeneSPP1C1458155Mammary Neoplasms2CTD_human
HgeneSPP1C1565662Acute Kidney Insufficiency2CTD_human
HgeneSPP1C2609414Acute kidney injury2CTD_human
HgeneSPP1C2930617Pulmonary Fibrosis - from Asbestos Exposure2CTD_human
HgeneSPP1C4704874Mammary Carcinoma, Human2CTD_human
HgeneSPP1C0006118Brain Neoplasms1CTD_human
HgeneSPP1C0007282Carotid Stenosis1CTD_human
HgeneSPP1C0013221Drug toxicity1CTD_human
HgeneSPP1C0017638Glioma1CTD_human
HgeneSPP1C0017668Focal glomerulosclerosis1CTD_human
HgeneSPP1C0018799Heart Diseases1CTD_human
HgeneSPP1C0018824Heart valve disease1CTD_human
HgeneSPP1C0019193Hepatitis, Toxic1CTD_human
HgeneSPP1C0019207Hepatoma, Morris1CTD_human
HgeneSPP1C0019208Hepatoma, Novikoff1CTD_human
HgeneSPP1C0020517Hypersensitivity1CTD_human
HgeneSPP1C0022658Kidney Diseases1CTD_human
HgeneSPP1C0023890Liver Cirrhosis1CTD_human
HgeneSPP1C0023896Alcoholic Liver Diseases1CTD_human
HgeneSPP1C0023904Liver Neoplasms, Experimental1CTD_human
HgeneSPP1C0024668Mammary Neoplasms, Experimental1CTD_human
HgeneSPP1C0027627Neoplasm Metastasis1CTD_human
HgeneSPP1C0027659Neoplasms, Experimental1CTD_human
HgeneSPP1C0030286Pancreatic Diseases1CTD_human
HgeneSPP1C0032229Pleural Neoplasms1CTD_human
HgeneSPP1C0032285Pneumonia1CTD_human
HgeneSPP1C0032300Lobar Pneumonia1CTD_human
HgeneSPP1C0033687Proteinuria1CTD_human
HgeneSPP1C0034069Pulmonary Fibrosis1CTD_human
HgeneSPP1C0041755Adverse reaction to drug1CTD_human
HgeneSPP1C0041948Uremia1CTD_human
HgeneSPP1C0086404Experimental Hepatoma1CTD_human
HgeneSPP1C0086432Hyalinosis, Segmental Glomerular1CTD_human
HgeneSPP1C0153633Malignant neoplasm of brain1CTD_human
HgeneSPP1C0162820Dermatitis, Allergic Contact1CTD_human
HgeneSPP1C0239946Fibrosis, Liver1CTD_human
HgeneSPP1C0259783mixed gliomas1CTD_human
HgeneSPP1C0270612Leukoencephalopathy1CTD_human
HgeneSPP1C0340569Internal Carotid Artery Stenosis1CTD_human
HgeneSPP1C0496899Benign neoplasm of brain, unspecified1CTD_human
HgeneSPP1C0555198Malignant Glioma1CTD_human
HgeneSPP1C0750974Brain Tumor, Primary1CTD_human
HgeneSPP1C0750977Recurrent Brain Neoplasm1CTD_human
HgeneSPP1C0750979Primary malignant neoplasm of brain1CTD_human
HgeneSPP1C0751633Carotid Artery Plaque1CTD_human
HgeneSPP1C0751634Carotid Ulcer1CTD_human
HgeneSPP1C0751635Common Carotid Artery Stenosis1CTD_human
HgeneSPP1C0751636External Carotid Artery Stenosis1CTD_human
HgeneSPP1C0853897Diabetic Cardiomyopathies1CTD_human
HgeneSPP1C0860207Drug-Induced Liver Disease1CTD_human
HgeneSPP1C0887898Experimental Lung Inflammation1CTD_human
HgeneSPP1C1262760Hepatitis, Drug-Induced1CTD_human
HgeneSPP1C1527304Allergic Reaction1CTD_human
HgeneSPP1C1527390Neoplasms, Intracranial1CTD_human
HgeneSPP1C1858991Childhood Ataxia with Central Nervous System Hypomyelinization1CTD_human
HgeneSPP1C2937358Cerebral Hemorrhage1CTD_human
HgeneSPP1C3658290Drug-Induced Acute Liver Injury1CTD_human
HgeneSPP1C3714636Pneumonitis1CTD_human
HgeneSPP1C4277682Chemical and Drug Induced Liver Injury1CTD_human
HgeneSPP1C4279912Chemically-Induced Liver Toxicity1CTD_human
HgeneSPP1C4721411Osteolysis1CTD_human
HgeneSPP1C4721507Alveolitis, Fibrosing1CTD_human
TgeneC0001973Alcoholic Intoxication, Chronic1PSYGENET
TgeneC0024623Malignant neoplasm of stomach1CTD_human
TgeneC0036341Schizophrenia1PSYGENET
TgeneC0038356Stomach Neoplasms1CTD_human
TgeneC0266463Lissencephaly1CTD_human
TgeneC0266483Pachygyria1CTD_human
TgeneC0557874Global developmental delay1GENOMICS_ENGLAND
TgeneC1708349Hereditary Diffuse Gastric Cancer1CTD_human
TgeneC1879312Agyria1CTD_human
TgeneC3714756Intellectual Disability1GENOMICS_ENGLAND
TgeneC4748540CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 91GENOMICS_ENGLAND